Evening Primrose Oil for PCOS: What the Trial Evidence Actually Shows

Is There Any PCOS Trial Evidence for Evening Primrose Oil?

Yes — one. A PubMed search for evening primrose oil and gamma-linolenic acid trials in PCOS turns up exactly two human, PCOS-specific randomised trials, and only one is still standing. Seventy-six women with PCOS completed a 12-week, placebo-controlled trial of 1,000 mg daily evening primrose oil, published in 2024 — the only PCOS-specific trial that hasn’t been retracted. The other, an earlier and far more widely cited trial pairing it with vitamin D, was formally retracted in 2024 after years as the paper most PCOS content actually points to. That leaves one small, unreplicated trial as the entire PCOS-specific evidence base — not zero, as its evidence elsewhere might suggest, but not much more than zero either.

What the One Real PCOS Trial Actually Found

The 2024 trial randomised 80 unmarried women aged 18–24 with PCOS in Sanandaj, Iran, to 1,000 mg of evening primrose oil or a matched placebo daily for 12 weeks; 76 completed it, 38 per group. Regular cycles rose from 2.6% to 42.1% on evening primrose oil, against 7.9% to 13.2% on placebo (p=0.04). Insulin (p=0.01), testosterone (p=0.03), and the free androgen index (p=0.03) fell more in the treatment group; sex hormone binding globulin (SHBG) rose more (p=0.04).

None of that moved what a person can see or feel: hirsutism (p=0.22), follicle count (p=0.21), and ovarian volume (p=0.80) all showed no significant change. The trial calls its participants “adolescent,” but the population was unmarried women 18–24, not teenagers. It also carries an unflagged conflict: the study oil and placebo were both supplied by Barij Essence, a herbal-extract manufacturer, and one co-author is affiliated with that company’s research center, though the paper reports no conflict of interest.

The Trial You’ll Actually Find First Is Retracted

Search a little further and the trial you’re more likely to land on isn’t the 2024 one — it’s an older, better-indexed 2018 trial testing evening primrose oil plus vitamin D in 60 vitamin-D-deficient women with PCOS, which reported improved triglycerides and oxidative-stress markers. That paper carries an expression of concern from 2020 and was formally retracted in 2024 — after roughly six years as the study most secondary sources cite as “the” PCOS evidence for it. Its senior author also sits on the citation-integrity watchlist this site checks every supplement claim against: a body of roughly 35 retracted papers across one prolific research group. A clean-looking PCOS trial with that name attached is worth verifying before it’s trusted, and this one no longer holds up.

What Evening Primrose Oil Is Actually Proven to Help

Evening primrose oil is pressed from Oenothera biennis seeds and runs roughly 60–80% linoleic acid and 8–14% gamma-linolenic acid (GLA), an omega-6 fatty acid profile the body converts into anti-inflammatory and vasoactive compounds. Its reputation as a women’s-hormone supplement predates PCOS entirely — it comes from decades of use for cyclic breast pain (mastalgia) and premenstrual syndrome, and neither holds up as well as the reputation suggests.

The largest mastalgia trial ever run — 120 women, six months, against a corn-oil control — found breast-pain days fell 12.3% on evening primrose oil and 13.8% on the control oil (p=0.73). A 2014 review of mastalgia treatment put it plainly: “gamma-linolenic acid or evening primrose oil though commonly prescribed is not effective”.

PMS fares no better. A 2011 review of ten PMS trials found chasteberry beat placebo across four trials, while evening primrose oil showed no effect different from placebo — a verdict a separate clinical review reached too, for both mastalgia and PMS.

That’s the pattern PCOS marketing borrows from: a reputation built in two unrelated conditions, before later trials in those same conditions mostly failed to confirm it.

Interactions and Safety Worth Knowing

Evening primrose oil’s GLA is metabolised into dihomo-gamma-linolenic acid and then series-1 prostaglandins, which reduce platelet clumping — a real, measurable effect. Rabbits given evening primrose oil for 30 to 60 days showed significantly prolonged clotting times and lower platelet counts. In one human case, a newborn had bruising and petechiae after her mother took thirteen 500 mg capsules in the week before delivery — though the infant’s platelet count came back normal, so it doesn’t prove a bleeding disorder. A 2022 review of its use around childbirth found reported adverse events included bleeding and concluded the practice isn’t recommended. If you notice unusual bruising, bleeding gums, blood in urine or stool, or a cut that won’t stop oozing, stop the supplement and tell whoever is treating you — especially if you take warfarin, aspirin, clopidogrel, another blood thinner, or have surgery or dental work scheduled.

Evening primrose oil also carries a decades-old, contested seizure caution, tracing to a 1981 case report of three hospitalised, treatment-resistant schizophrenia patients whose EEGs showed temporal-lobe-seizure activity after starting it; their symptoms resolved once the anti-seizure drug carbamazepine was added. A 2007 re-examination argued the causal link was never established and that its fatty acids may be mildly anti-seizure rather than pro-seizure. It still appears in drug-interaction references warning against combining it with anticonvulsants, and phenothiazine antipsychotics independently lower seizure threshold as a class effect — a reason not to stack an unresolved risk on a confirmed one. If you notice a sudden blank stare, a rising fear or unfamiliar smell with no clear cause, jerking movements, or confusion afterward, stop and call your prescriber or neurologist right away — particularly if you take an antipsychotic, an anticonvulsant, or have a seizure history.

You may also see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organisations renamed it. None of the evidence gaps above change under either name — this article uses PCOS because that’s still what people search.

Who This Won’t Help

Measured against this site’s supplements and medications section, evening primrose oil is among the thinnest-evidenced PCOS options, resting on one small, unreplicated trial. It will not help:

• Anyone wanting a PCOS-trial-backed hormone treatment. The 2023 international PCOS guideline doesn’t mention evening primrose oil at all — an absence, not a rejection, because the trial base barely existed when it was written. For what does have trial support, from inositol to vitamin D, start there instead.
• Anyone hoping to see or feel a physical difference. The one PCOS trial moved blood hormone levels but not hirsutism, follicle count, or ovarian volume — the outcomes most people actually want changed.
• Anyone wanting an omega-3-style effect studied in PCOS. Evening primrose oil is an omega-6 fatty acid; omega-3s have their own, separately tested PCOS trial evidence and aren’t interchangeable with it.
• Anyone on a blood thinner, an antipsychotic, or an anticonvulsant who hasn’t checked with a prescriber first — see above.
• Anyone pregnant or hoping to use it to prepare for labor. The best available review found it isn’t recommended for that use.

Three other botanicals sold for PCOS sit in a similar spot: DIM has no PCOS trials at all, three small black seed oil trials exist but only one was placebo-controlled, and vitex has one PCOS-specific trial plus a stronger PMS record. Evening primrose oil’s PCOS evidence is thinner than any of them — one small, unreplicated trial, against one retracted trial that used to outrank it.

Common questions